Comprehensive Guide to US FDA OTC Monograph-Compliant Products by Taj Pharma

We present a complete, structured, and regulatory-aligned overview of US FDA OTC Monograph-Based Products offered and feasible under Taj Pharma’s pharmaceutical manufacturing and export capabilities. This detailed guide is curated to support US OTC private labeling, FDA OTC drug listing, contract manufacturing, and global exports under the OTC Monograph Reform (OMOR) framework.

All products listed herein are non-prescription (OTC) drug products recognized under US FDA OTC monographs, meaning they do not require NDA or ANDA approval, provided they strictly comply with monograph conditions for formulation, strength, dosage form, labeling, claims, and manufacturing controls.

Generic NameStrengthFormCategoryIndicationMonograph
Diphenhydramine HCl25 mg, 50 mgTablets, Capsules, Oral LiquidAntihistamine / Sleep AidAllergy relief, nighttime sleep aid, motion sicknessCold, Cough, Allergy & Sleep Aid Monograph (M012 / M010)
Chlorpheniramine Maleate2 mg, 4 mgTablets, SyrupAntihistamineAllergic rhinitis, hay feverCold, Cough, Allergy Monograph (M012)
Dimetindene Maleate1 mgTablets, Oral DropsAntihistamineAllergy symptom reliefCold, Cough, Allergy Monograph (M012)
Doxylamine Succinate25 mgTabletsSleep AidTemporary insomniaNighttime Sleep-Aid Monograph (M010)
Dimenhydrinate50 mgTablets, Chewable TabletsAntiemeticMotion sickness, nauseaAntiemetic Drug Products Monograph (M009)
Acetaminophen325 mg, 500 mg, 650 mgTablets, Caplets, Extended-Release TabletsAnalgesic / AntipyreticMild to moderate pain, feverInternal Analgesic Monograph (M013)
Aspirin81 mg, 325 mgTablets, Chewable TabletsAnalgesic / AntipyreticPain, fever, cardiovascular prophylaxisInternal Analgesic Monograph (M013)
Ibuprofen200 mgTablets, Capsules, SoftgelsNSAID AnalgesicPain, inflammation, feverInternal Analgesic Monograph (M013)
Calcium Carbonate500 mg, 750 mgChewable TabletsAntacidHeartburn, acid indigestionAntacid Monograph (M001)
Magnesium Hydroxide400 mg/5 mlOral SuspensionAntacid / LaxativeAcid indigestion, constipationAntacid / Laxative Monograph (M001 / M007)
Simethicone80 mg, 125 mgChewable Tablets, SoftgelsAntiflatulentGas reliefAntiflatulent Monograph (M002)
Bismuth Subsalicylate262 mgTablets, Oral SuspensionAntidiarrhealDiarrhea, upset stomachAntidiarrheal Monograph (M008)
Loperamide HCl2 mgCapsules, TabletsAntidiarrhealAcute diarrheaAntidiarrheal Monograph (M008)
Psyllium Husk3.4 gPowder, GranulesBulk-forming laxativeConstipationLaxative Monograph (M007)
Bisacodyl5 mg, 10 mgTablets, SuppositoriesStimulant laxativeConstipationLaxative Monograph (M007)
Senna Extract8.6 mgTabletsHerbal laxativeConstipationLaxative Monograph (M007)
Menthol5–10%Gel, Cream, Roll-onExternal AnalgesicMuscle & joint painExternal Analgesic Monograph (M017)
Methyl Salicylate10–30%Ointment, CreamExternal AnalgesicMuscle pain, arthritisExternal Analgesic Monograph (M017)
Camphor3–11%Balm, OintmentExternal AnalgesicPain reliefExternal Analgesic Monograph (M017)
Capsaicin0.025–0.1%CreamExternal AnalgesicNeuropathic painExternal Analgesic Monograph (M017)
Zinc Oxide10–40%Cream, OintmentSkin ProtectantDiaper rash, minor burnsSkin Protectant Monograph (M016)
Calamine8–25%LotionSkin ProtectantItching, insect bitesSkin Protectant Monograph (M016)
Allantoin0.5–2%Cream, LotionSkin ProtectantWound healingSkin Protectant Monograph (M016)
Hydrocortisone0.5–1%Cream, OintmentAnti-itchDermatitis, rashesTopical Corticosteroid Monograph (M020)
Clotrimazole1%Cream, LotionAntifungalAthlete’s foot, ringwormTopical Antifungal Monograph (M005)
Miconazole Nitrate2%Cream, PowderAntifungalFungal skin infectionsTopical Antifungal Monograph (M005)
Tolnaftate1%Cream, SprayAntifungalTinea infectionsTopical Antifungal Monograph (M005)
Undecylenic Acid10–25%Liquid, OintmentAntifungalAthlete’s footTopical Antifungal Monograph (M005)
Benzoyl Peroxide2.5%, 5%, 10%Gel, CreamAnti-acneAcne vulgarisAcne Drug Products Monograph (M006)
Salicylic Acid0.5–2%Gel, LotionAnti-acneAcneAcne Drug Products Monograph (M006)
Sulfur3–10%Ointment, SoapAnti-acneAcneAcne Drug Products Monograph (M006)
Carboxymethylcellulose0.5–1%Ophthalmic Solution (Drops)Artificial TearsDry eyesOphthalmic Monograph (M018)
Naphazoline0.012–0.03%Ophthalmic Solution (Drops)VasoconstrictorEye rednessOphthalmic Monograph (M018)
Carbamide Peroxide6.5%Otic DropsOticEar wax removalOtic Drug Products Monograph (M014)
Sodium Fluoride0.02–0.243%Toothpaste, Oral RinseAnticariesPrevent dental cariesOral Health Care Monograph
Hydrogen Peroxide1.5–3%Oral RinseOral debriding agentMinor oral woundsOral Health Care Monograph
Zinc Oxide10–25%Cream, LotionSunscreenUV protectionSunscreen Monograph (21 CFR 352)
Titanium Dioxide2–25%Cream, LotionSunscreenUV protectionSunscreen Monograph (21 CFR 352)

Regulatory Notes (Important)

  • All above products are Monograph-based OTC drugs in the USA
  • No NDA/ANDA required if formulation, strength, labeling, and claims strictly comply
  • Subject to OTC Monograph Reform (OMOR) → administrative orders instead of CFR finals
  • Ideal for US OTC private label, export registration, or US FDA OTC listing

Understanding US FDA OTC Monograph-Based Drugs

US FDA OTC monographs function as a “recipe book” for OTC drugs, defining:

  • Permitted active ingredients
  • Acceptable strengths
  • Approved dosage forms
  • Allowed indications and claims
  • Mandatory labeling language

With the implementation of OTC Monograph Reform (OMOR), these requirements are now governed through administrative orders, enabling faster updates while maintaining regulatory rigor.


Allergy, Cold, Sleep Aid & Antiemetic OTC Products

These products represent some of the highest-volume OTC categories in the United States, particularly in seasonal allergy, flu, and motion sickness segments.

Key Monograph Coverage

  • Cold, Cough & Allergy Monograph (M012)
  • Nighttime Sleep-Aid Monograph (M010)
  • Antiemetic Drug Products Monograph (M009)

Product Highlights

  • Diphenhydramine HCl (25 mg, 50 mg) in tablets, capsules, oral liquids for allergy relief, sleep aid, and motion sickness
  • Chlorpheniramine Maleate (2 mg, 4 mg) tablets and syrups for allergic rhinitis
  • Doxylamine Succinate (25 mg) tablets for temporary insomnia
  • Dimenhydrinate (50 mg) chewable and standard tablets for nausea and motion sickness

These formulations are widely accepted for retail OTC branding, pharmacy chains, and supermarket distribution across the USA.


Analgesic & Antipyretic OTC Products

Pain relief and fever management remain cornerstone OTC categories globally.

Applicable Monograph

  • Internal Analgesic, Antipyretic & Antirheumatic Monograph (M013)

OTC Staples

  • Acetaminophen (325 mg, 500 mg, 650 mg) in tablets, caplets, and extended-release forms
  • Aspirin (81 mg, 325 mg) including chewable tablets
  • Ibuprofen (200 mg) tablets, capsules, and softgels

These products are essential for mass retail, hospital OTC shelves, and export-led private labels.


Gastrointestinal OTC Products

GI-related OTC medicines show consistent demand due to lifestyle-related digestive issues.

Relevant Monographs

  • Antacid Monograph (M001)
  • Antiflatulent Monograph (M002)
  • Antidiarrheal Monograph (M008)

Key Products

  • Calcium Carbonate (500 mg, 750 mg) chewable antacids
  • Magnesium Hydroxide (400 mg/5 ml) oral suspension
  • Simethicone (80 mg, 125 mg) chewables and softgels
  • Bismuth Subsalicylate (262 mg) tablets and suspension
  • Loperamide HCl (2 mg) capsules and tablets

These products align strongly with US retail compliance and export dossier simplification.


Laxatives & Constipation Management Products

OTC laxatives remain high-turnover SKUs in pharmacy and wellness outlets.

Applicable Monograph

  • Laxative Drug Products Monograph (M007)

Core Products

  • Psyllium Husk (3.4 g) powders and granules
  • Bisacodyl (5 mg, 10 mg) tablets and suppositories
  • Senna Extract (8.6 mg) herbal laxative tablets

These products offer excellent private-label scalability with minimal regulatory barriers.


Topical Analgesics for Muscle & Joint Pain

Topical pain relief products are increasingly preferred due to localized action and safety profile.

Applicable Monograph

  • External Analgesic Monograph (M017)

Monograph-Compliant Actives

  • Menthol (5–10%)
  • Methyl Salicylate (10–30%)
  • Camphor (3–11%)
  • Capsaicin (0.025–0.1%)

Available in gels, creams, ointments, roll-ons, and balms, these products are ideal for sports, arthritis, and elderly care segments.


Dermatological & Skin Protectant OTC Products

Skin protection and minor dermatological treatments represent high-frequency OTC purchases.

Relevant Monographs

  • Skin Protectant Monograph (M016)
  • Topical Corticosteroid Monograph (M020)

Product Range

  • Zinc Oxide (10–40%) creams and ointments
  • Calamine (8–25%) lotions
  • Allantoin (0.5–2%) creams and lotions
  • Hydrocortisone (0.5–1%) creams and ointments

These products comply with pediatric, adult, and sensitive-skin OTC labeling standards.


Topical Antifungal OTC Products

Fungal infections are a global OTC category with consistent demand.

Applicable Monograph

  • Topical Antifungal Monograph (M005)

Key Products

  • Clotrimazole 1%
  • Miconazole Nitrate 2%
  • Tolnaftate 1%
  • Undecylenic Acid (10–25%)

Forms include creams, lotions, sprays, powders, and liquids, supporting athlete’s foot, ringworm, and jock itch claims.


OTC Acne Treatment Products

Acne remains a top dermatology OTC segment, particularly among adolescents and young adults.

Applicable Monograph

  • Acne Drug Products Monograph (M006)

Monograph Actives

  • Benzoyl Peroxide (2.5%, 5%, 10%)
  • Salicylic Acid (0.5–2%)
  • Sulfur (3–10%)

Available in gels, creams, lotions, soaps, these products are ideal for cosmeceutical-OTC crossover markets.


Ophthalmic, ENT & Oral Care OTC Products

Monographs Covered

  • Ophthalmic Monograph (M018)
  • Otic Drug Products Monograph (M014)
  • Oral Health Care Monograph

Products

  • Carboxymethylcellulose (0.5–1%) artificial tear drops
  • Naphazoline (0.012–0.03%) redness relief eye drops
  • Carbamide Peroxide (6.5%) ear wax removal drops
  • Sodium Fluoride (0.02–0.243%) toothpaste and rinses
  • Hydrogen Peroxide (1.5–3%) oral debriding rinses

These categories align with daily-use OTC compliance and repeat-purchase consumer behavior.


Sunscreen OTC Products

Applicable Regulation

  • Sunscreen Monograph (21 CFR 352)

Approved Actives

  • Zinc Oxide (10–25%)
  • Titanium Dioxide (2–25%)

Available in creams and lotions, these products meet broad-spectrum UV protection requirements and are essential for OTC dermatology portfolios.


Regulatory & Commercial Advantages

  • No NDA / ANDA required when monograph conditions are met
  • Fully aligned with OTC Monograph Reform (OMOR)
  • Faster market entry and scalability
  • Ideal for US FDA OTC listing, private labeling, and exports
  • Compatible with WHO-GMP and PIC/S manufacturing standards

This US FDA OTC Monograph-Based Product List by Taj Pharma represents a strategic, compliant, and commercially viable OTC portfolio designed for US retail markets and global exports. With strong alignment to FDA monographs, these products offer regulatory clarity, reduced approval timelines, and scalable manufacturing opportunities for brand owners and distributors worldwide.